NCT00072085View on ClinicalTrials.gov

Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2003

Study Completion Date

July 31, 2006

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

gp100 antigen

BIOLOGICAL

incomplete Freund's adjuvant

Trial Locations (2)

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00072085 - Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter